Family gatherings at the holidays are the perfect time to learn more about your family's health history. A few thoughtful questions can go a long way to revealing how you can work to prevent future disease and improve your health.
In this month's Genomics Landscape, Dr. Green describes NHGRI's use of social media to spread messages about the institute and genomics. He also highlights an event for military families at the Genome: Unlocking Life's Code exhibition in San Diego; recent publications from the Mouse ENCODE Project; and the new chief of NHGRI's Genomic Hea […]
On November 10, Robert Wildin, M.D., a clinical geneticist with nearly three decades of experience in private and hospital-based medical practice, joined NHGRI as chief of the Genomic Healthcare Branch (GHB). As GHB chief, Dr. Wildin will provide leadership in promoting the integration of genomic discoveries into clinical and public health practice.
Detailed exhibit information, media contacts and images available for companies and centers.Smarter home systems, better batteries, more wearable tech, and totally outside-the-box electronics with the potential to usher in the next generation of high-tech living can be ... More at http://www.nsf.gov/news/news_summ.jsp?cntn_id=133651&WT.mc_id=USNSF_51 […]
The rate at which carbon emissions warmed Earth's climate almost 56 million years ago resembles modern, human-caused global warming much more than previously believed, but involved two pulses of carbon to the atmosphere, researchers have found.The findings mean that the so-called Paleocene-Eocene thermal maximum, or PETM, can provide clues to the future […]
The Life Sciences Discovery Fund today announced $1.2 million in Proof of Concept grants to Washington-based organizations to foster the advancement of promising health-related technologies to commercial products. Also announced were two commercialization-focused awards, totaling $600,000, through a new funding program requiring external cash matching.
Type 1 diabetes (T1D) patients who have developed low blood sugar (hypoglycemia) as a complication of insulin treatments over time are able to regain normal internal recognition of the condition after receiving pancreatic islet cell transplantation, according to a new study led by researchers at the Perelman School of Medicine at the University of Pennsylvan […]
Programmed cell death is a mechanism that causes defective and potentially harmful cells to destroy themselves. It serves a number of purposes in the body, including the prevention of malignant tumor growth. Now, researchers at Technische Universität München have discovered a previously unknown mechanism for regulating programmed cell death.
Funding Provided by:
The National Science Foundation
Ohio University | 510 Porter Hall
Athens, Ohio 45701 | 740 593-1120